Abstract | BACKGROUND: METHODS: A PC model was developed by implanting a syngeneic 0.25 cm(3) tumor into Fisher 344 rats' omentum. Rats were grouped as follow: No surgery (Ø CS), cytoreductive surgery alone (CS), and CS + Ad-HSV-UTK + gancyclovir (GCV). 10(9) Ad-HSV-UTK was injected intraperitoneally (i.p.) and GCV (50 mg/kg) was administered i.p. every other day, beginning on postoperative day 2. The Kaplan-Meier survival method and log-rank test were statistical tests used. RESULTS: Treated rats had a significantly longer median and overall survival than the Ø CS and CS groups (P = .012). The median survivals for the treated rats, Ø CS, CS were 18 days, 9 days, and 11 days, respectively. CONCLUSIONS:
|
Authors | Kerry Byrnes, Benjamin D L Li, Neal Holm, Jie Li, Yoshi Okadata, Arrigo De Benedetti, A Nedeljkovic-Kurepa, Michael Mathis, Quyen D Chu |
Journal | Surgery
(Surgery)
Vol. 142
Issue 2
Pg. 270-5
(Aug 2007)
ISSN: 0039-6060 [Print] United States |
PMID | 17689695
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- Eukaryotic Initiation Factor-4E
- Ganciclovir
|
Topics |
- Adenocarcinoma
(surgery, therapy)
- Adenoviridae
(genetics)
- Animals
- Antiviral Agents
(pharmacology)
- Cell Line, Tumor
- Combined Modality Therapy
- Disease Models, Animal
- Eukaryotic Initiation Factor-4E
(genetics)
- Female
- Ganciclovir
(pharmacology)
- Gene Expression Regulation, Neoplastic
- Genes, Transgenic, Suicide
- Genetic Therapy
(methods)
- Mammary Neoplasms, Animal
(surgery, therapy)
- Neoplasm Transplantation
- Neoplasm, Residual
(surgery, therapy)
- Omentum
- Peritoneal Neoplasms
(surgery, therapy)
- Rats
- Rats, Inbred F344
- Survival Rate
|